We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.005 | 0.11% | 4.65 | 4.41 | 4.89 | 4.53 | 4.51 | 4.53 | 241,784 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 22/7/2020 19:51 | Especially with that snake Morris somewhere in the background ! | paradise city | |
| 22/7/2020 19:31 | Valirx is dodgy as. Ramp followed by placings etc. Been there done that. But DYOR. | tricky red | |
| 22/7/2020 18:57 | I agree share price will easily double by Oct. This is the gold standard treatment for sure in the making. Probability of launch i think is above 80% given the initial safty and high efficacy signal!! We know mode of action well and its a natural chemical agent | elsol | |
| 22/7/2020 18:43 | Hoping for major licensing deals /JVs or a takeover by year-end. In either case I hope the share price will be multiples of what it is now. | sloppyjoe2 | |
| 22/7/2020 18:35 | This has just started. Let the day traders exit. | richardjohn10 | |
| 22/7/2020 18:34 | Tidy can't open the link. Please let me know the key points. Thanks | bag158s | |
| 22/7/2020 18:11 | Synairgen's coronavirus cure may prove more useful and timely than potential vaccines. htTTps://www.google. | tidy 2 | |
| 22/7/2020 17:27 | He's a Pi Seems he sold some to get back his initial stake. He was holding for some time before April. | tidy 2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
